Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ajona

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|April 30, 2019
Complementing the Cancer-Immunity CycleRuben Pio, Daniel Ajona, Sergio Ortiz-Espinosa, et al.
Immunological Reviews|October 27, 2016
Innate immune mediators in cancer: between defense and resistancePedro Berraondo, Luna Minute, Daniel Ajona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growthDaniel Ajona, Yi-Fan Hsu, Leticia Corrales, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Radiation effects on antitumor immune responses: current perspectives and challengesThomas Walle, Rafael Martinez Monge, Adelheid Cerwenka, et al.
Iscience|June 22, 2026
Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathwayLucie Colineau, Olga Kolodziej, Daniel Ajona, et al.
EMBO Molecular Medicine|February 7, 2014
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtypeMarta Larrayoz, Ruben Pio, María J Pajares, et al.
Molecular Cancer|June 10, 2010
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivoYi-Fan Hsu, Daniel Ajona, Leticia Corrales, et al.
Cancer Research|September 3, 2004
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complementDaniel Ajona, Zafira Castaño, Mercedes Garayoa, et al.
Neoplasia (New York, N.Y.)|August 3, 2013
Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironmentJavier Freire, Daniel Ajona, Gabriel de Biurrun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 3, 2012
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progressionLeticia Corrales, Daniel Ajona, Stavros Rafail, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|April 30, 2019
Complementing the Cancer-Immunity CycleRuben Pio, Daniel Ajona, Sergio Ortiz-Espinosa, et al.
Immunological Reviews|October 27, 2016
Innate immune mediators in cancer: between defense and resistancePedro Berraondo, Luna Minute, Daniel Ajona, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2007
Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growthDaniel Ajona, Yi-Fan Hsu, Leticia Corrales, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Radiation effects on antitumor immune responses: current perspectives and challengesThomas Walle, Rafael Martinez Monge, Adelheid Cerwenka, et al.
Iscience|June 22, 2026
Type 2 and type 1 diabetes have opposing effects on the systemic murine complement alternative pathwayLucie Colineau, Olga Kolodziej, Daniel Ajona, et al.
EMBO Molecular Medicine|February 7, 2014
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtypeMarta Larrayoz, Ruben Pio, María J Pajares, et al.
Molecular Cancer|June 10, 2010
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivoYi-Fan Hsu, Daniel Ajona, Leticia Corrales, et al.
Cancer Research|September 3, 2004
Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complementDaniel Ajona, Zafira Castaño, Mercedes Garayoa, et al.
Neoplasia (New York, N.Y.)|August 3, 2013
Silica-induced chronic inflammation promotes lung carcinogenesis in the context of an immunosuppressive microenvironmentJavier Freire, Daniel Ajona, Gabriel de Biurrun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 3, 2012
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progressionLeticia Corrales, Daniel Ajona, Stavros Rafail, et al.
Pageof 6